Isavuconazole pharmacokinetics in a patient with cystic fibrosis following bilateral orthotopic lung transplantation
- 7 March 2018
- journal article
- case report
- Published by Wiley in Transplant Infectious Disease
- Vol. 20 (3) , e12878
Abstract
Previous studies of patients with cystic fibrosis (CF) treated with azole antifungals have shown altered pharmacokinetics relative to healthy patients. Data regarding the pharmacokinetic profile of isavuconazole in patients with CF undergoing lung transplantation are currently not available. Serum trough concentrations assessed in a single CF patient following transplant revealed significantly lower values relative to available literature. Larger studies are required to validate CF population pharmacokinetics of isavuconazole.Keywords
This publication has 14 references indexed in Scilit:
- Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysisThe Lancet Infectious Diseases, 2016
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2016
- Population Pharmacokinetics of Isavuconazole in Subjects with Mild or Moderate Hepatic ImpairmentAntimicrobial Agents and Chemotherapy, 2016
- Isavuconazole as salvage therapy for mucormycosisMedical Mycology Case Reports, 2016
- Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trialThe Lancet, 2016
- Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal AgentPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2015
- Isavuconazole: A New Broad-Spectrum Triazole Antifungal AgentClinical Infectious Diseases, 2015
- Pharmacological considerations for azole antifungal drug management in cystic fibrosis lung transplant patientsMedical Mycology, 2010
- Bioavailability and Population Pharmacokinetics of Voriconazole in Lung Transplant RecipientsAntimicrobial Agents and Chemotherapy, 2010
- In VitroAntifungal Activity of Isavuconazole against 345 Mucorales Isolates Collected at Study Centers in Eight CountriesJournal of Chemotherapy, 2009